Mode of action of adjuvants: implications for vaccine safety and design.
Mastelic B, Ahmed S, Egan WM, Del Giudice G, Golding H, Gust I, Neels P, Reed SG, Sheets RL, Siegrist CA, Lambert PH.
Mastelic B, et al.
Biologicals. 2010 Sep;38(5):594-601. doi: 10.1016/j.biologicals.2010.06.002. Epub 2010 Jul 24.
Biologicals. 2010.
PMID: 20659806